Christopher Todd's most recent trade in Tamboran Resources Corp. was a trade of 123,574 Common Stock done . Disclosure was reported to the exchange on Jan. 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tamboran Resources Corp | Todd Abbott Christopher | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2026 | 123,574 | 156,234 | - | 0 | Common Stock | |
| Tamboran Resources Corp | Todd Abbott Christopher | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2026 | 32,660 | 32,660 | - | 0 | Common Stock | |
| Park Dental Partners Inc | Todd Christopher Gerlach | Director | Purchase of securities on an exchange or from another person at price $ 13.00 per share. | 03 Dec 2025 | 7,692 | 68,847 | - | 13 | 99,996 | Common Stock |
| Safe Pro Grp Inc | Christopher Todd | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2024 | 25,000 | 25,000 | - | - | Stock Options (right to buy) | |
| Globe Life | Christopher Todd Moore | Corp.SVP, Assoc.Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Apr 2022 | 882 | 0 | - | - | Employee Stock Option (right to buy) | |
| Globe Life | Christopher Todd Moore | Corp.SVP, Assoc.Counsel & Sec | Sale of securities on an exchange or to another person at price $ 104.22 per share. | 22 Apr 2022 | 882 | 0 (0%) | 0% | 104.2 | 91,921 | Common Stock |
| Globe Life | Christopher Todd Moore | Corp.SVP, Assoc.Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 50.69 per share. | 22 Apr 2022 | 882 | 882 (0%) | 0% | 50.7 | 44,712 | Common Stock |
| NovoCure Ltd | Todd Christopher Longsworth | General Counsel | Sale of securities on an exchange or to another person at price $ 70.10 per share. | 08 Mar 2022 | 2,339 | 62,462 (0%) | 0% | 70.1 | 163,964 | Ordinary Shares |
| NovoCure Ltd | Todd Christopher Longsworth | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 6,106 | 6,106 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Todd Christopher Longsworth | General Counsel | Sale of securities on an exchange or to another person at price $ 70.41 per share. | 03 Mar 2022 | 1,973 | 64,801 (0%) | 0% | 70.4 | 138,913 | Ordinary Shares |
| NovoCure Ltd | Todd Christopher Longsworth | General Counsel | Sale of securities on an exchange or to another person at price $ 74.50 per share. | 03 Mar 2022 | 1,094 | 66,774 (0%) | 0% | 74.5 | 81,501 | Ordinary Shares |
| Globe Life | Christopher Todd Moore | Corp.SVP, Assoc.Counsel & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 6,500 | 6,500 | - | - | Employee Stock Option (right to buy) |